Consultation opens on guide to China for Australian medtech companies


Thursday, 20 November, 2014

AusBiotech and an expert advisory panel have developed a draft ‘China Guide’ for Australian medtech companies and AusBiotech is now seeking comment.

The guide aims to assist small to medium-sized Australian medical technology companies (medical devices and diagnostics) that are seeking to engage with and in China. It is part of a larger project which has received funding support from the Australian Trade Commission under the Asian Business Engagement grants program.

The guide and the broader project seek to facilitate medtech trade and partnership with China by breaking down the information barriers for Australian companies about intellectual property (IP) management in China and the types of business structures that are possible for Australian companies engaging in China. The guide includes introductory information, including business and cultural details, and the regulatory context that a medtech company may consider in a strategy for China. The guide does not intend to be exhaustive or to take the place of professional advice. Instead, it is to serve as a starting point for Australian companies.

The consultation closes 27 February 2015 and the completed China Guide will be officially launched at AusMedtech 2015 (29-30 April 2015).

How to contribute to the consultation

Comments are invited from interested parties. Reviewers may wish to consider the following questions:

  • Is there any section or information that is superfluous/missing?
  • Is the flow/structure appropriate?
  • Does any section need re-wording to increase clarity?
  • Is any information now redundant, factually incorrect or superseded?

Comments should be specific and tracking changes is encouraged, so that your intention is clearly understood. The draft Word document can be accessed via the Project Manager (details below) or it may be found here.

Please provide comments, submissions and/or enquiries to Project Manager Lorraine Chiroiu, AusBiotech, by emailing lchiroiu@ausbiotech.org or calling (03) 9828 1414 or 0429 801 118.

Related News

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd